Glucotrack regains Nasdaq compliance with stockholders' equity rule
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
August 17, 2026 8:00 AM EDTRUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq's stockholders' equity requirement. The decision represents an important milestone in the Company's efforts to strengthen its foundation and position for future growth.
This is an important milestone, but more significantly, it is an acknowledgment of the substantial progress we have made in repositioning... More
